Dundalk-based Dr Anita Finnegan, founder of cybersecurity firm Nova Leah, has been nominated for a prestigious EU Prize for Women Innovators award, of the 13 females shortlisted in the main category of the competition.
Her nomination is only the second time an Irish innovator has been selected for the award since they launched nine years ago. Nova Leah, founded in 2015, is a cybersecurity start-up that develops risk assessment software for connected medical devices. Their Irish and European base is in the Finnabair Industrial Estate in Dundalk.
Having begun life in the Regional Development Centre at Dundalk Institute of Technology, the company’s backers include Sure Valley Ventures, Cosimo Ventures and Enterprise Ireland. Nova Leah is a world leader in the provision of cybersecurity solutions for medical device manufacturers and healthcare providers and has picked up numerous awards since it’s founding five years ago. The company launched SelectEvidence in 2016, an expert cybersecurity risk management platform for connected medical devices.
“It is an honour to be included on this list of outstanding innovators,” Dr Finnegan said. “These awards provide female entrepreneurs from across Europe a platform for recognition and inclusion, and motivate more women to push themselves forward and turn their ideas into commercial reality,” said Dr Finnegan.
The winners will be announced in September. A prize of €100,000 is awarded to each of the top three winners of the competition.
The awards were launched in 2011 to help raise awareness of the need for more female entrepreneurs. Although there are more women than men in Europe, figures show that just 16% of start-ups on the continent are founded or co-founded by women.
Dr Finnegan is an internationally recognised expert in Medical Device Cybersecurity. She has completed a BE Degree, BS Degree, Diploma and PhD – all at Dundalk Institute of Technology.